SBI Healthcare Opportunities Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1909 Cr | ₹3963 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.14 | 1.94 |
Manager | Dhruv Muchhal | Pradeep Kesavan |
ISIN Code | INF179KC1HL7 | INF200K01446 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | 0.64% | 0.49% |
6 Month | 15.19% | 10.17% |
1 Year | 7.36% | 3.11% |
3 Year | - | 26.25% |
5 Year | - | 19.97% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | 5.23% | 2.71% |
1 Year | 15.8% | 8.35% |
3 Year | - | 24.24% |
5 Year | - | 21.01% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 29.56% | 16.04% |
3 Year | - | 17.71% |
5 Year | - | 12.85% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | - | 13.91% |
Sharp | - | 1.28% |
Beta | - | 0.84% |
Alpha | - | 4.16% |
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Dhruv Muchhal | Pradeep Kesavan |
Total AUM | ₹520687 Cr | ₹434274 Cr |
Funds Managed | 40 | 43 |
HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 8.17 | 13.76 |
Mid Cap | 27.19 | 27.24 |
Small Cap | 35.64 | 32.93 |
Large Cap | 29 | 26.07 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 1.1 | 3.85 |
Basic Materials | 2.44 | 5.79 |
Healthcare | 96.46 | 90.36 |
Top Comparisons
Bandhan Banking & PSU Fund - Regular Growth
3Y Returns7.16%
Axis Banking & PSU Debt Fund - Regular Plan - Growth option
3Y Returns7.12%
SBI Savings Fund - Regular Plan - Growth
3Y Returns7.05%
HSBC Money Market Fund - Regular Growth
3Y Returns7.18%
BAJAJ FINSERV BANKING AND PSU FUND REGULAR PLAN GROWTH
3Y Returns0%
Tata Banking & PSU Debt Fund-Regular Plan-Growth
3Y Returns4.96%
Mahindra Manulife Small Cap Fund - Regular Plan - Growth
3Y Returns0%
HSBC Small Cap Fund Regular Growth
3Y Returns19.91%